Clinical Trial Update: REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

View source ↗

Summary

A clinical trial update on the REAL-CARE study evaluating the real-world effectiveness of iptacopan in Italian patients with paroxysmal nocturnal hemoglobinuria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Status: RECRUITING